Cargando…

Subtype and prognostic analysis of immunogenic cell death-related gene signature in prostate cancer

BACKGROUND: Immunogenic cell death (ICD) plays a vital role in tumor progression and immune response. However, the integrative role of ICD-related genes and subtypes in the tumor microenvironment (TME) in prostate cancer (PCa) remains unknown. MATERIALS AND METHODS: The sample data were obtained fro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, Zhen, Sun, Jiang-Bo, Lin, Fei, Huang, Xu-Yun, Huang, Qi, Chen, Dong-Ning, Zheng, Qing-Shui, Xue, Xue-Yi, Xu, Ning, Wei, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10279955/ https://www.ncbi.nlm.nih.gov/pubmed/37346077 http://dx.doi.org/10.3389/fonc.2023.1160972

Ejemplares similares

Ubiquitination-Related Molecular Subtypes and a Novel Prognostic Index for Bladder Cancer Patients
por: Cai, Hai, et al.
Publicado: (2021)

Angiogenesis-Related Molecular Subtypes and a Novel Prognostic Signature in Clear Cell Renal Cell Carcinoma Patients
por: Li, Hao, et al.
Publicado: (2021)

Construction of immunogenic cell death-related molecular subtypes and prognostic signature in colorectal cancer
por: Yu, Chun, et al.
Publicado: (2023)

Molecular Subtypes and CD4(+) Memory T Cell-Based Signature Associated With Clinical Outcomes in Gastric Cancer
por: Ning, Zhi-Kun, et al.
Publicado: (2021)

Immunogenic Cell Death-Relevant Damage-Associated Molecular Patterns and Sensing Receptors in Triple-Negative Breast Cancer Molecular Subtypes and Implications for Immunotherapy
por: Xu, Ming, et al.
Publicado: (2022)

Identification of Immunogenic Cell-Death-Related Subtypes and Development of a Prognostic Signature in Gastric Cancer
por: Gan, Xuejun, et al.
Publicado: (2023)

The prognostic value and response to immunotherapy of immunogenic cell death-associated genes in breast cancer
por: Zhao, Rongling, et al.
Publicado: (2023)

Identification of cuproptosis-based molecular subtypes, construction of prognostic signature and characterization of immune landscape in colon cancer
por: Wang, Xu, et al.
Publicado: (2023)

Risk Factors for Pathologically Confirmed Lymph Nodes Metastasis in Patients With Clinical T2N0M0 Stage Prostate Cancer
por: Xu, Ning, et al.
Publicado: (2020)

Identification of immunosuppressive signature subtypes and prognostic risk signatures in triple-negative breast cancer
por: Ding, Ran, et al.
Publicado: (2023)

Identification of an immune subtype-related prognostic signature of clear cell renal cell carcinoma based on single-cell sequencing analysis
por: Fan, Zongyao, et al.
Publicado: (2023)

Identification of marker genes and cell subtypes in castration-resistant prostate cancer cells
por: Lin, Xiao-Dan, et al.
Publicado: (2021)

Distinguishable Prognostic Signatures and Tumor Immunogenicity Between Pancreatic Head Cancer and Pancreatic Body/Tail Cancer
por: Ge, Weiyu, et al.
Publicado: (2022)

Construction and comprehensive analysis of a novel prognostic signature associated with immunogenic cell death molecular subtypes in patients with bladder cancer
por: Gu, Lei, et al.
Publicado: (2023)

Development and validation of a novel hypoxia-related signature for prognostic and immunogenic evaluation in head and neck squamous cell carcinoma
por: Li, Su-Ran, et al.
Publicado: (2022)

Molecular Subtypes and Prognostic Signature of Pyroptosis-Related lncRNAs in Glioma Patients
por: Tanzhu, Guilong, et al.
Publicado: (2022)

Development and validation of prognostic index based on immunogenic cell death-related genes with melanoma
por: Han, Yajun, et al.
Publicado: (2022)

A Transcription Factor Signature Can Identify the CMS4 Subtype and Stratify the Prognostic Risk of Colorectal Cancer
por: Zhong, Min-Er, et al.
Publicado: (2022)

Prognostic Implications of Molecular Subtypes in Primary Small Cell Lung Cancer and Their Correlation With Cancer Immunity
por: Qi, Jing, et al.
Publicado: (2022)

Identification and Validation of a Prognostic Signature for Prostate Cancer Based on Ferroptosis-Related Genes
por: Liu, Huan, et al.
Publicado: (2021)

An integrative multi-omics analysis based on disulfidptosis-related prognostic signature and distinct subtypes of clear cell renal cell carcinoma
por: Zhang, Dong, et al.
Publicado: (2023)

Identification of Subtype-Specific Metastasis-Related Genetic Signatures in Sarcoma
por: Li, Ya-Ling, et al.
Publicado: (2020)

Development and Validation of Novel Biomarkers Related to M2 Macrophages Infiltration by Weighted Gene Co-Expression Network Analysis in Prostate Cancer
por: Xu, Ning, et al.
Publicado: (2021)

Development and Validation of a 6-Gene Hypoxia-Related Prognostic Signature For Cholangiocarcinoma
por: Sun, Qi, et al.
Publicado: (2022)

A Novel Ferroptosis-Based Molecular Signature Associated with Biochemical Recurrence-Free Survival and Tumor Immune Microenvironment of Prostate Cancer
por: Ke, Zhi-Bin, et al.
Publicado: (2022)

Identification of novel molecular subtypes and a signature to predict prognosis and therapeutic response based on cuproptosis-related genes in prostate cancer
por: Zhang, Jili, et al.
Publicado: (2023)

Construction of a prognostic signature associated with liver metastases for prognosis and immune response prediction in colorectal cancer
por: Liu, Chang, et al.
Publicado: (2023)

A Novel Ferroptosis-Related 4-Gene Prognostic Signature for Cholangiocarcinoma and Photodynamic Therapy
por: Zhang, Zi-jian, et al.
Publicado: (2021)

Immunogenic sonodynamic therapy for inducing immunogenic cell death and activating antitumor immunity
por: Wang, Ting, et al.
Publicado: (2023)

Identification of Subtype-Specific Three-Gene Signature for Prognostic Prediction in Diffuse Type Gastric Cancer
por: Bao, Bowen, et al.
Publicado: (2019)

Mitochondria Dysfunction-Mediated Molecular Subtypes and Gene Prognostic Index for Prostate Cancer Patients Undergoing Radical Prostatectomy or Radiotherapy
por: Feng, Dechao, et al.
Publicado: (2022)

Immunogenomic Landscape and Immune-Related Gene-Based Prognostic Signature in Asian Gastric Cancer
por: Mao, Chenchen, et al.
Publicado: (2021)

Identification of Metabolism-Associated Prostate Cancer Subtypes and Construction of a Prognostic Risk Model
por: Zhang, Yanlong, et al.
Publicado: (2020)

ND630 controls ACACA and lipid reprogramming in prostate cancer by regulating the expression of circKIF18B_003
por: Wu, Yu-Peng, et al.
Publicado: (2023)

Immunogenic Cell Death and Immunomodulatory Effects of Cabozantinib
por: Scirocchi, Fabio, et al.
Publicado: (2021)

Identification of N6-Methyladenosine-Related lncRNAs as a Prognostic Signature in Glioma
por: Chen, Yujia, et al.
Publicado: (2022)

Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma
por: Li, Wang, et al.
Publicado: (2020)

Prostate cancer epidemiology and prognostic factors in the United States
por: Abudoubari, Saimaitikari, et al.
Publicado: (2023)

Transcriptomic signature defines two subtypes of locally advanced PCa with distinct neoadjuvant therapy benefits
por: Zhu, Yinjie, et al.
Publicado: (2023)

Development of an immunogenic cell death prognostic signature for predicting clinical outcome and immune infiltration characterization in stomach adenocarcinoma
por: Liu, Ye, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e1fpjqb5an3csoe1u0simgab12